Phathom Pharmaceuticals, Inc. (PHAT)
6.92
-0.16
(-2.26%)
USD |
NASDAQ |
Oct 02, 16:00
6.935
+0.02
(+0.22%)
After-Hours: 20:00
Phathom Pharmaceuticals Profit Margin (Quarterly) : -23.67% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.67% |
| March 31, 2026 | -52.09% |
| December 31, 2025 | -36.73% |
| September 30, 2025 | -60.55% |
| June 30, 2025 | -191.9% |
| March 31, 2025 | -330.7% |
| Date | Value |
|---|---|
| December 31, 2024 | -251.0% |
| September 30, 2024 | -523.3% |
| June 30, 2024 | -1.25K% |
| March 31, 2024 | -4.33K% |
| December 31, 2023 | -11.67K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -35.83% |
| Return on Invested Capital | -55.15% |
| Gross Profit Margin (Quarterly) | 79.68% |
| Operating Margin (Quarterly) | -5.34% |
| Return on Net Operating Assets | -121.8% |